Company / SG&A per Share
Immunome Inc. SG&A per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.68
FY2025
5-year range
$0.45 / $1.12
FY2021-FY2025
Trend
+49.4%
vs FY2024
Sector context
#149 of 210
Health Care
What the data says
At $0.68, Immunome Inc.'s sg&a per share ranks #62 of 210 in the Health Care sector. SG&A per Share returned to growth in FY2025 after 2 years of decline, reaching $0.68.
Based on SEC 10-K filings.
0.68 in FY2025 with a 5-year CAGR of -13.6%.
Improved from $1.12 to $0.68 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -15.5%
- 5-Year CAGR
- -13.6%
- 10-Year CAGR
- -
Sector benchmark
#62 of 210 in Health CareTop 29% of 210This company $0.68 Sector average $29.50
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 49.4% year-over-year.
- Ranks #149 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
- Lowest sg&a per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.68 | +49.4% |
| FY2024 | $0.45 | -59.6% |
| FY2023 | $1.12 | -0.0% |
| FY2022 | $1.12 | +16.9% |
| FY2021 | $0.96 | -31.7% |
| FY2020 | $1.41 | +1.1% |
| FY2019 | $1.39 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026